Decreased growth during therapy with selective serotonin reuptake inhibitors

Archives of Pediatrics and Adolescent Medicine

Volumn 156, Issue 7, 2002, Pages 696-701

  Weintrob, Naomi ^a,b   Cohen, Daniela ^b   Klipper Aurbach, Yaffa ^b   Zadik, Zvi ^c   Dickerman, Zvi ^b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; ESTROGEN; GLUCAGON; GROWTH HORMONE; HUMAN GROWTH HORMONE; HYDROCORTISONE; PROLACTIN; SEROTONIN UPTAKE INHIBITOR; THYROTROPIN;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE AGE; CASE REPORT; DOSE RESPONSE; FEMALE; FOLLOW UP; GILLES DE LA TOURETTE SYNDROME; GROWTH HORMONE RELEASE; GROWTH RATE; GROWTH RETARDATION; HUMAN; HYPOPHYSIS FUNCTION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MENTAL DISEASE; OBSESSION; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD;

EID: 0036315424     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.156.7.696     Document Type: Article

References (29)

1. The new antidepressants: Selective serotonin reuptake inhibitors
2. Fluvoxamine: A review of its therapeutic potential in the management of anxiety disorders in children and adolescents
3. More fluoxetine experience
4. Galactorrhea induced by sertraline
5. Effect of fluoxetine on noradrenergic mediated growth hormone release: A double blind, placebo-controlled study
6. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder
7. Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity
8. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: Blunted temperature and hormone responses to ipsapirone challenge
9. Decreased sensitivity of 5-HT(1D) receptors in melancholic depression
10. Open fluoxetine treatment of mixed anxiety disorders in children and adolescents
11. Fluvoxamine for the treatment of anxiety disorders in children and adolescents
12. Fluoxetine in child and adolescent depression: Acute and maintenance treatment
13. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled multicenter trial
14. Effects of nefazodone on body weight: A pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials
15. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty
16. Variations in pattern of pubertal changes in girls
17. Variation in the pattern of pubertal changes in boys
18. Use and abuse of growth standards
19. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys
20. Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation
21. Growth hormone neurosecretory dysfunction: A treatable cause of short stature
22. Neural control of somatotropic function
23. Effects of alpha- and beta-adrenergic agonists and antagonists on growth hormone secretion in man
24. Psychoneuroendocrinology of depression: Growth hormone
25. Comparison between four immunoassays for growth hormone (GH) measurement as guides to clinical decisions following GH provocative tests
26. Combined clonidine-short-ACTH test for the simultaneous assessment of growth hormone reserve and hypothalamic-pituitary-adrenal axis integrity in children
27. Effect of short-term stimulation of serotoninergic pathways on the pulsatile secretion of luteinizing hormone in the absence and presence of acute opiate-receptor blockage
28. Transitory growth hormone deficiency successfully treated with human growth hormone